BIOMARIN PHARMACEUTICAL INC (BMRN) /
The debt of BIOMARIN PHARMACEUTICAL INC over the past 10 years
Chart BIOMARIN PHARMACEUTICAL INC: liquid cash, total debt, net cash, fiscal 2016–2025 Open the chart →At the end of fiscal 2025, the latest fiscal year on file, BIOMARIN PHARMACEUTICAL INC had liquid cash of $1.56B and total debt of $597.18M: net cash of $963.43M. It had more liquid cash than debt at 6 of the 10 year-ends shown. Total debt was highest at the end of fiscal 2017 ($1.17B) and lowest at the end of fiscal 2024 ($595.14M).
Year by year
| Fiscal year | Liquid cash | Total debt* | Net cash* |
|---|---|---|---|
| 2025ended Dec 31, 2025 | $1.56B* | $597.18M | $963.43M |
| 2024ended Dec 31, 2024 | $1.14B* | $595.14M | $542.57M |
| 2023ended Dec 31, 2023 | $1.07B* | $1.09B | -$13.16M |
| 2022ended Dec 31, 2022 | $1.29B* | $1.08B | $208.52M |
| 2021ended Dec 31, 2021 | $1.01B* | $1.08B | -$65.2M |
| 2020ended Dec 31, 2020 | $1.07B* | $1.08B | -$9.76M |
| 2019ended Dec 31, 2019 | $753.81M* | $848.12M | -$94.31M |
| 2018ended Dec 31, 2018 | $1.08B* | $830.42M | $253.89M |
| 2017ended Dec 31, 2017 | $1.4B* | $1.17B | $221.5M |
| 2016ended Dec 31, 2016 | $789.68M* | $683.24M | $106.44M |
Fiscal years as BIOMARIN PHARMACEUTICAL INC reports them. * Calculated by us from the company's filed figures; — no figure on file. From SEC filings, updated nightly. How each line is read.
More on BIOMARIN PHARMACEUTICAL INC
- The revenue of BIOMARIN PHARMACEUTICAL INC
- The profitability of BIOMARIN PHARMACEUTICAL INC
- The cash flow of BIOMARIN PHARMACEUTICAL INC
- All of BIOMARIN PHARMACEUTICAL INC's financials, charted
Companies of a similar size
Not investment advice. This page shows what BIOMARIN PHARMACEUTICAL INC filed with the SEC. Nothing here is a recommendation about any security. Check important figures against the company's own filings.